PKAIX
Price
$13.49
Change
+$0.05 (+0.37%)
Updated
Dec 23 closing price
RMFEX
Price
$55.30
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
Ad is loading...

PKAIX vs RMFEX

Header iconPKAIX vs RMFEX Comparison
Open Charts PKAIX vs RMFEXBanner chart's image
PIMCO RAE US Instl
Price$13.49
Change+$0.05 (+0.37%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R4
Price$55.30
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
PKAIX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PKAIX vs. RMFEX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKAIX is a StrongBuy and RMFEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 102B vs. PKAIX (1.56B). PKAIX pays higher dividends than RMFEX: PKAIX (2.62) vs RMFEX (1.95). PKAIX was incepted earlier than RMFEX: PKAIX (10 years) vs RMFEX (23 years). PKAIX is a more actively managed with annual turnover of: 77.00 vs. RMFEX (25.00). RMFEX has a lower initial minimum investment than PKAIX: RMFEX (250) vs PKAIX (1000000). RMFEX annual gain was more profitable for investors over the last year : 11.51 vs. PKAIX (2.46). RMFEX return over 5 years is better than : 40.52 vs. PKAIX (26.25).
PKAIXRMFEXPKAIX / RMFEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD1.88810.76018%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B102B2%
Annual Yield % from dividends2.621.95135%
Returns for 1 year2.4611.5121%
Returns for 3 years5.2212.4042%
Returns for 5 years26.2540.5265%
Returns for 10 yearsN/A65.11-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GHRS7.000.15
+2.19%
GH Research PLC
EVEX5.090.08
+1.60%
Eve Holding
BEST2.640.02
+0.76%
BEST
HALO47.160.20
+0.43%
Halozyme Therapeutics
MCK576.76-2.98
-0.51%
McKesson Corp